🚨 First BGB Product Live: Tadalafil API
≥99% HPLC purity | Factory-direct
⏰ Golden Phase: 18-26 March = Best price (up to 50% off)
🕒 Silver Phase: 27 Mar-6 Apr = 20-25% off
📅 Final Phase: 7 Apr+ = Standard pricing
MOQ: 1kg only
#AASraw#APIManufacturer#Tadalafil
Furthermore, GLP-1 reduces de novo hepatic fat synthesis and decreases lipid flow from the liver to abdominal fat. Multiple imaging studies (CT or MRI measurements) have confirmed a significant reduction in visceral fat area in patients using GLP-1 drugs.
Reducing visceral fat requires a comprehensive approach including dietary control, resistance training, sufficient sleep, and stress management. GLP-1 receptor agonists, as a potent medical tool, can also significantly reduce visceral fat.
Visceral fat is inflammatory tissue that can increase your disease risk in a major way.
Higher visceral fat is associated with up to a 44% higher risk of several major cancers, including colon, pancreatic, and liver cancer, and this persists even after accounting for waist circumference (suggesting visceral fat itself is a key driver and not just body size). Visceral fat releases inflammatory molecules that can damage cells over time and may even cause normal cells to become cancerous.
It tracks with longevity too. Studies using waist circumference as a proxy for visceral fat find people with higher abdominal/visceral fat are about 2 times more likely to die early compared with those without high central fat.
If you care about long-term healthspan, reducing visceral fat is one of the most impactful targets.
Clip from my recent appearance on @ThomasDeLauer podcast!
For age-related or primary hypotestosteronism, GLP-1 cannot replace TRT, but the combination of the two can produce synergistic benefits—GLP-1 promotes fat loss, while TRT helps maintain lean body mass and bone density.
For men with obesity-related hypotestosteronism, GLP-1 inhibitors can be a treatment, but monitoring of muscle mass and improvement is necessary. If testosterone levels don't reach the desired level or muscle loss is significant after 8-12 weeks, combined TRT should be considered
GLP-1 drugs do not directly stimulate testosterone secretion, but rather create conditions for hormonal balance by improving the metabolic environment.
GLP-1s & Testosterone: What's the link? 🤔 Weight loss from GLP-1s like Ozempic & Trizepatide CAN improve testosterone levels—if you prioritize protein & resistance training to maintain muscle mass! #GLP1#Testosterone#WeightLoss#Ozempic#Trizepatide#renamalikmd
Muscle mass and strength are primarily regulated by testosterone, but estradiol's protective role in bone metabolism is equally important in men; deficiency increases the risk of bone loss.
Regarding sexual function, estradiol and testosterone work together to maintain normal libido and erectile function. When estradiol levels are below 10 pg/mL, the decrease in libido scores in men (31%) is significantly greater than in those with normal estradiol levels (13%).